gla 27 has been researched along with Pseudomonas Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, A; Homma, JY; Ikeda, S; Kiso, M; Kumazawa, Y; Matsuura, M; Nakatsuka, M; Nishimura, C | 1 |
| Hasegawa, A; Homma, JY; Ikeda, S; Kiso, M; Kumazawa, Y; Nakatsuka, M; Nishimura, C; Yamamoto, A | 1 |
2 other study(ies) available for gla 27 and Pseudomonas Infections
| Article | Year |
|---|---|
Enhancement of nonspecific resistance to microbial infections of synthetic lipid A-subunit analogues of GLA-27 modified at the C1 position of the glucosamine backbone.
Topics: Animals; Female; Immunity, Innate; Interferons; Killer Cells, Natural; Lipid A; Mice; Mice, Inbred ICR; Pseudomonas Infections; Structure-Activity Relationship; Vaccinia | 1990 |
Antitumor and antimicrobial activities of lipid A-subunit analogue GLA-27.
Topics: Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Antiviral Agents; Drug Evaluation, Preclinical; Lipid A; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Pseudomonas Infections; Vaccinia | 1988 |